Lexston Life Sciences Corp
  • Home
  • The Company
    • About Lexston
    • Officers & Directors
    • Investors
    • News Releases
    • Legal, Banking & T/A
    • Projects
  • Contact Us
  • More
    • Home
    • The Company
      • About Lexston
      • Officers & Directors
      • Investors
      • News Releases
      • Legal, Banking & T/A
      • Projects
    • Contact Us
Lexston Life Sciences Corp
  • Home
  • The Company
    • About Lexston
    • Officers & Directors
    • Investors
    • News Releases
    • Legal, Banking & T/A
    • Projects
  • Contact Us

News releases July 2022 onwards

January 18, 2023 Change of Business (pdf)Download
October 17, 2022 Resignation of Director (pdf)Download
October 6, 2022 correction to date for the Stock Option Grant (pdf)Download
October 3, 2022 Stock Option grant (pdf)Download
September 12, 2022 BOD addition (pdf)Download
September 8, 2022 Resignation of Director (pdf)Download
August 11, 2022 Results of Annual General and Special Meeting (pdf)Download
July 4, 2022 Closing of the Private Placement (pdf)Download

News releases January to June | 2022

June 27, 2022 Private Placement increased (pdf)Download
June 15, 2022 resignation of Philippe Henry as Director and CSO (pdf)Download
June 9. 2022 Subsidiaries lay off staff (pdf)Download
June 3, 2022 Cancellation of options (pdf)Download
June 1, 2022 Private Placement (pdf)Download
May 20, 2022 Share Consolidation (pdf)Download
May 13, 2022 Share Consolidation (pdf)Download
April 11, 2022 Allenii Project (pdf)Download
March 25, 2022 appointment of CFO (pdf)Download
Jan 31, 2022 Section 56 exemption (pdf)Download
Jan 24, 2022 Egret-8SNP (pdf)Download
Jan 19, 2022 Egret-NRCirap (pdf)Download
Jan 14, 2022 Market Activity (pdf)Download
Jan 12, 2022 MOU ALVARIUS (pdf)Download
Jan 10 2022 MOU Panacea (pdf)Download

News releases | 2021

Dec 15, 2021 DTC ELIGIBILITY (pdf)Download
Nov 15, 2021 OTC listing (pdf)Download
Nov 11, 2021 Lexston NR re STOCK OPTION GRANT (pdf)Download
Sept 28, 2021 Psy (pdf)Download
Sept 23, 2021 RESEARCH and DEVELOPMENT (pdf)Download
Sept 20, 2021 ACQUISITION OF ZEN (pdf)Download
Sept 9, 2021 LEXT retains marketing consultant (pdf)Download
July 13, 2021 Section 56 update (pdf)Download
July 7, 2021 Psy PP (pdf)Download
July 5, 2021 STOCK OPTION GRANT (pdf)Download
June 30, 2021 BOD Graeme Staley (pdf)Download
June 23, 2021 initial release (pdf)Download
June 21 2021 CSE - New Listing - Lexston Life Sciences Corp_ (pdf)Download

Copyright © 2023 Lexston Life Sciences Corp - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept